Form 4 for COR Cencora
Accepted 2021-07-14 00:00:00 ET · period of report 2021-07-13 · accession 0001127602-21-021921 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-14 | 2021-07-13 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | S - Sale+OE | $114.90 | -20.9K | 186.8K | -10% | -$2.40M |
| D | 2021-07-14 | 2021-07-13 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | M - OptEx | $88.71 | +18.7K | 207.7K | +10% | +$1.66M |
| D | 2021-07-14 | 2021-07-13 | COR | COLLIS STEVEN H | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -18.7K | 18.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-13 | S | D | 20,912 | $114.90 | 186,825 | D | — | — | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. |
| 2 | Common | Common Stock | 2021-07-13 | M | A | 18,666 | $88.71 | 207,737 | D | — | — | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. |
| 3 | Derivative | Non-qualified Stock Option (Right to Buy) | 2021-07-13 | M | D | 18,666 | $0.00 | 18,666 | D | $88.71 · — to 2021-11-12 | 18,666 Common Stock | (F1) The sale of stock reflected in this Form 4 was affected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person effective February 12, 2021 and disclosed in the Company's 8-K filed with the Securities and Exchange Commission on February 18, 2021. (F2) Exercisable in four equal annual installments on 11/12/15, 11/12/16, 11/12/17 and 11/12/18. |